What's new? Log in Free sign up

Filing search / Standard BioTools Inc. / "Tax"

Search information

Standard BioTools Inc.

Companies

"Tax"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

287 results

Newest first Best match first

LAB Standard BioTools Inc.

Quarterly report

, non-current Deferred tax liability Operating lease liabilities, non-current Deferred revenue, non-current Deferred grant income, non-current Other … Loss before income taxes Income tax expense Net loss Induced conversion of redeemable preferred stock Net loss attributable to common stockholders Net

6 Nov 24

5:17pm

LAB Standard BioTools Inc.

Standard BioTools Reports Third Quarter 2024 Financial Results

before income taxes Income tax benefit (expense) Net loss Induced conversion of redeemable preferred stock Net loss attributable to common … , current Convertible notes, current Total current liabilities Convertible notes, non-current Term loan, non-current Deferred tax liability Operating

Notice of proposed sale of securities

> Y Sale includes an amount necessary to cover a tax obligation resulting from

LAB Standard BioTools Inc.

Departure of Directors or Certain Officers

or benefits paid under this Plan would result in imposition of an additional tax under Section 409A of the Code (as defined below) if the foregoing … definition of “Change of Control” were to apply, but would not result in the imposition of any additional tax if the term “Change of Control” were defined

LAB Standard BioTools Inc.

Quarterly report

-current Deferred tax liability Operating lease liabilities, non-current Deferred revenue, non-current Deferred grant income, non-current Other non … Loss from operations Bargain purchase gain Interest income, net Other income (expense), net Loss before income taxes Income tax benefit (expense) Net

6 Aug 24

4:30pm

6cgwdbls9 rvazkws2n

Standard BioTools Reports Second Quarter 2024 Financial Results

Departure of Directors or Certain Officers

dkzxvape6kj ffj8

Notice of proposed sale of securities

Notice of proposed sale of securities

qh7e6 lv0otlxqqvg5q

Notice of proposed sale of securities

rs18qmj6tgss fnm

Shelf registration

18 Jun 24

5:43pm

Shelf registration

18 Jun 24

5:43pm

Shelf registration

18 Jun 24

5:43pm

Proxy in contested solicitation

u9er9vlb 6j3ysals69

Preliminary revised proxy

Preliminary proxy with contested solicitation

Quarterly report

9 May 24

4:53pm

uftplj951aw5 vv

Standard BioTools Reports First Quarter 2024 Financial Results

Annual report (amended)

26 Apr 24

5:01pm

x8d82lqd5wtllj8jnoe

Notice of proposed sale of securities

Prev
1
2
3
4
5
...
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.